Advancell

Index
Globenewswire

AdvanCell’s 212Pb-ADVC001 Demonstrates Encouraging Safety and Compelling Anti-tumor Activity in Phase 1b in Prostate Cancer

Globenewswire

AdvanCell Appoints Experienced Biotech and Pharma Leader, Andrew Kay, as Chair of the Board of Directors

Globenewswire

AdvanCell to Highlight the Potential of Pb-212-based Targeted Alpha Therapies for Cancer at EANM’25